Abstract
Introduction and aimsInfliximab (IFX) is a recognised effective therapy in moderate to severe inflammatory bowel disease (IBD). There has been an evolvement in IBD management towards a treat-to-target approach, with...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
